1 |
MARCH B, FAULKNER S, JOBLING P, et al. Tumour innervation and neurosignalling in prostate cancer[J]. Nat Rev Urol, 2020, 17(2):119-130.
|
2 |
顾佳敏,朱 聪,訾 豪,等.1990-2019年中国良性前列腺增生疾病负担分析[J].解放军医学杂志,2021,46(10):984-988.
|
3 |
NUHN P, DE BONO J S, FIZAZI K, et al. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology[J]. Eur Urol, 2019, 75(1): 88-99.
|
4 |
GARCIA-MAYEA Y, MIR C, MASSON F, et al. Insights into new mechanisms and models of cancer stem cell multidrug resistance[J]. Semin Cancer Biol, 2020, 60: 166-180.
|
5 |
QUINN D I, SANDLER H M, HORVATH L G, et al. The evolution of chemotherapy for the treatment of prostate cancer[J]. Ann Oncol, 2017, 28 (11): 2658-2669.
|
6 |
MCALLISTER S S, WEINBERG R A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis[J]. Nat Cell Biol, 2014,16 (8) : 717-727.
|
7 |
周晓洁,于 湄,田卫东.前成脂细胞及其临床应用潜能研究进展[J].解放军医学杂志,2022,47(2):178-185.
|
8 |
GONZALEZ H, HAGERLING C, WERB Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression[J].Genes Dev,2018,32(19/20): 1267-1284.
|
9 |
DENARDO D G, RUFFELL B. Macrophages as regulators of tumour immunity and immunotherapy[J]. Nat Rev Immunol, 2019,19 (6) : 369-382.
|
10 |
GUZEL E, KARATAS O F, DUZ M B, et al. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer[J].Prostate,2014,74(15):1498-1505.
|
11 |
SONER B C, AKTUG H, ACIKGOZ E, et al. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol[J]. Int J Mol Med, 2014,34(5):1249-1256.
|
12 |
FABRIS L, CEDER Y, CHINNAIYAN A M, et al. The potential of MicroRNAs as prostate cancer biomarkers[J]. Eur Urol, 2016, 70 (2): 312-322.
|
13 |
SISTIGU A, MUSELLA M, GALASSI C, et al. Tuning cancer fate: tumor microenvironment’s role in cancer stem cell quiescence and reawakening[J]. Front Immunol, 2020,11: 2166.
|
14 |
ARORA S, DEV K, AGARWAL B, et al. Macrophages: Their role, activation and polarization in pulmonary diseases[J].Immunobiology,2018,223(4/5):383-396.
|
15 |
DU T, YANG C L, GE M R, et al. M1 macrophage derived exosomes aggravate experimental autoimmune neuritis via modulating Th1 response[J]. Front Immunol, 2020, 11: 1603.
|
16 |
YAMAGUCHI T, FUSHIDA S, YAMAMOTO Y, et al. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination[J]. Gastric Cancer, 2016, 19 (4): 1052-1065.
|
17 |
SALMI S, SIISKONEN H, SIRONEN R, et al. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma[J]. Melanoma Res, 2019, 29(3) : 237-247.
|
18 |
ZHENG Y, CAI Z, WANG S, et al. Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis[J]. Blood, 2009, 114 (17): 3625-3628.
|
19 |
WU S Q, XU R, LI X F, et al. Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis[J]. Oncotarget, 2018, 9 (38): 25294-25303.
|
20 |
WEI C, YANG C G, WANG S Y, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis[J]. Mol Cancer, 2019, 18(1):64.
|
21 |
RIGO A, GOTTARDI M, ZAMÒ A, et al. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12[J]. Mol Cancer, 2010, 9: 273.
|
22 |
LARIONOVA I, TUGUZBAEVA G, PONOMARYOVA A, et al. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers[J]. Front Oncol, 2020, 10: 566511.
|
23 |
王子龙, 李连军, 王慕文. 肿瘤相关巨噬细胞在泌尿系统肿瘤中的研究进展[J].泌尿外科杂志(电子版), 2019, 11(3):10-16.
|
24 |
李俊君, 常德贵, 董良, 等. PCa组织中血管生成拟态形成的分子通路研究进展[J].中国性科学, 2017, 26(5):5-8.
|